M&A Deal Summary

GTCR Acquires Biocoat

On November 2, 2022, private equity firm GTCR acquired chemicals company Biocoat from 1315 Capital

Acquisition Highlights
  • This is GTCR’s 2nd transaction in the Chemicals sector.
  • This is GTCR’s 128th transaction in the United States.
  • This is GTCR’s 3rd transaction in Pennsylvania.

M&A Deal Summary
Date 2022-11-02
Target Biocoat
Sector Chemicals
Buyer(s) GTCR
Sellers(s) 1315 Capital
Deal Type Secondary Buyout
Advisor(s) Piper Sandler & Co. (Financial)

Target

Biocoat

Horsham, Pennsylvania, United States
Biocoat develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical parameters. The company specializes in supplying lubricious hydrophilic coatings for medical devices to original equipment manufacturers and contract manufacturers. Biocoat is able to recommend contract coaters or to provide in-house coating services to aspiring medical device companies that need help with manufacturing. The company also sells diagnostic test kits in the reproductive market for use in male factor infertility. Biocoat was founded in 1991 and is based in Horsham, Pennsylvania.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GTCR

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1980
PE ASSETS 15.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

GTCR is a private equity firm that typically partners with management when pursuing acquisitions. The Firm looks to grow companies through build-on acquisitions, consolidations, and internal growth. GTCR will consider both equity and mezzanine capital commitments and concentrates its investment activity in consumer products & services, healthcare services, outsourced business services, technology, transaction processing, and pharma/medical products. GTCR was formed in 1980 and is based in Chicago, Illinois.

DEAL STATS #
Overall 132 of 143
Sector (Chemicals) 2 of 2
Type (Secondary Buyout) 31 of 33
State (Pennsylvania) 3 of 3
Country (United States) 128 of 138
Year (2022) 7 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-26 Harpula

Raleigh, North Carolina, United States

Harpula is focused on improving the efficiency of drug research and development, by acquiring companies and assets in the technology-enabled pharmaceutical solutions industry. Harpula was founded in 2022 and is based in Raleigh, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-16 Senske Services

Kennewick, Washington, United States

Senske Services is a regional provider of recurring subscription-based residential lawn care, pest control, and other home services. The Company serves over 80,000 residential and commercial customers across 16 branches in Washington, Utah, Idaho, and Colorado. Senske Services was founded in 1947 and is based in Kennewick, Washington.

Buy -

Seller(S) 1

SELLER

1315 Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2014
Size Small
Type Sector Focused
DESCRIPTION

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 3 of 4
Sector (Chemicals) 1 of 1
Type (Secondary Buyout) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 3 of 4
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-04 Innovative ECMO Concepts

Arcadia, Oklahoma, United States

Innovative ECMO Concepts is a staffing and training company that provides outsourced support for extracorporeal membrane oxygenation (ECMO) and perfusion in hospitals. Innovative ECMO Concepts was founded in 2014 and is based in Arcadia, Oklahoma.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-09 Verogen

San Diego, California, United States

Verogen is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California.

Sell $150M
Mergr

Product

Company

Legal